Literature DB >> 3196987

Hodgkin's disease complicating non-Hodgkin's lymphoma.

S L Shumak1, J Srigley, J Rusthoven, D H Cowan.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3196987      PMCID: PMC1268479     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.

Authors:  J G Krikorian; J S Burke; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

2.  Chronic lymphocytic leukemia in Hodgkin's disease. Report of a case and review of the literature.

Authors:  T Han
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

3.  The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

Authors:  S J Horning; S A Rosenberg
Journal:  N Engl J Med       Date:  1984-12-06       Impact factor: 91.245

4.  Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.

Authors:  D D Weisenburger; H Kim; H Rappaport
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

5.  Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.

Authors:  S M Hsu; E S Jaffe
Journal:  Am J Clin Pathol       Date:  1984-07       Impact factor: 2.493

Review 6.  Hodgkin's disease: biology, treatment, prognosis.

Authors:  H S Kaplan
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

7.  Association of non-Hodgkin's lymphoma (NHL) and second neoplasms.

Authors:  M H Zarrabi
Journal:  Semin Oncol       Date:  1980-09       Impact factor: 4.929

Review 8.  Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease.

Authors:  J O Armitage; F R Dick; J A Goeken; M K Foucar; R D Gingrich
Journal:  Arch Intern Med       Date:  1983-03

9.  MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

Authors:  P Klimo; J M Connors
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.